Debut Plus

₹10.5

▼ -0.5 -4.55%

18 Jul 2026

NSE Listed · Pharmaceuticals

JFL Life Sciences Limited (JFLLIFE)

Volume: 24,000Avg Vol 1W: 39,600Avg Vol 1M: 25,09152W Range:₹8.55₹15.55
NSE BSE www.jfllifesciences.com
Key Ratios
Checked just now
Market Cap₹35 Cr
Current Price₹10.5
Previous Close₹11
High / Low (52w)₹15.55 / ₹8.55
Volume24,000
Avg Vol (1W)39,600
Avg Vol (1M)25,091
Stock P/E21
Book Value₹13.9
Dividend Yield0%
ROE13.96%
ROA6.02%
Revenue (TTM)—
Revenue Growth—
Profit Margin487.1%
Total Debt—
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹1.94
P/B0.76
Debt / Equity0.22
50 DMA₹9.61
200 DMA₹10.71
Day change-4.55%
Price Chart
₹10.5▼ 29.25% · 1Y
₹23₹91.9L
2025-07-18
2026-07-17

20-day avg volume: 26K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 74% YoY.
  • Net profit is growing year over year.
  • Stock trades below its book value.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹10 Cr₹40 Cr₹21 Cr₹12 Cr₹12 Cr₹30 Cr₹27 Cr₹63 Cr
EBITDA₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr
Net Profit₹2 Cr₹1 Cr₹1 Cr₹0 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹32 Cr₹30 Cr₹33 Cr₹34 Cr₹44 Cr₹47 Cr₹82 Cr
EBITDA₹1 Cr₹2 Cr₹2 Cr₹6 Cr₹5 Cr₹5 Cr₹7 Cr
Net Profit₹0 Cr₹0 Cr₹1 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr
EPS0.590.660.894.122.911.26
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹16 Cr₹24 Cr₹29 Cr₹48 Cr₹49 Cr₹57 Cr₹72 Cr
Total Liabilities₹11 Cr₹19 Cr₹22 Cr₹37 Cr₹17 Cr₹21 Cr₹32 Cr
Equity₹5 Cr₹5 Cr₹7 Cr₹11 Cr₹32 Cr₹36 Cr₹39 Cr
Total Debt———————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-6 Cr₹2 Cr₹-8 Cr₹8 Cr₹-3 Cr
Investing₹-2 Cr₹-1 Cr₹1 Cr₹-6 Cr₹0 Cr
Financing₹7 Cr₹-1 Cr₹8 Cr₹-2 Cr₹4 Cr
Free Cash Flow₹-6 Cr₹2 Cr₹-8 Cr₹8 Cr₹-3 Cr
Shareholding
Promoter 67.47% Institutions 0% Public 32.53%
Efficiency & Working Capital
ROCE15.8%
Interest Coverage6.7
Dividend Payout—
Debtor Days155 d
Inventory Days103 d
Payable Days79 d
Cash Conversion Cycle180 d
Working Capital Days259 d
Shareholding Details

As of 2026-06-30

Promoter67.5%
FII0%
DII0%
Institutions0%
Public32.5%
Promoter Pledge0%
No. of Shareholders943
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2022Dec 2022Mar 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters67.5%67.5%67.5%67.5%67.5%67.5%67.5%67.5%67.5%67.5%67.5%67.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public32.5%32.5%32.5%32.5%32.5%32.5%32.5%32.5%32.5%32.5%32.5%32.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders9789218738328259669971,008998991971943
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Smiral Ashwinkumar PatelShareholding of Promoter and Promoter Group44.3%1.46 Cr
Tejal Smiral PatelShareholding of Promoter and Promoter Group16.6%54,71,154
Smiral Ashwinkumar Patel HufShareholding of Promoter and Promoter Group4%13,14,222
Pratik Rajendrabhai GandhiPublic Shareholding1.2%4,02,000
Ashwinbhai Jivrambhai PatelShareholding of Promoter and Promoter Group0.9%2,93,007
Patel DakshabenShareholding of Promoter and Promoter Group0.4%1,22,070
Rupesh Kirtibhai PatelShareholding of Promoter and Promoter Group0.3%1,10,760
Ashokkumar Parshottamdas PatelShareholding of Promoter and Promoter Group0.3%89,700
Ushaben Ashokkumar PatelShareholding of Promoter and Promoter Group0.2%70,200
Artiben Manishkumar PatelShareholding of Promoter and Promoter Group0.2%67,470
Shobhnaben Kirtikumar PatelShareholding of Promoter and Promoter Group0.2%58,110
Kirtikumar Parshottambhai PatelShareholding of Promoter and Promoter Group0.1%39,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Smiral Ashwinkumar Patel Huf00%2026-06-30
Ashwinbhai Jivrambhai Patel00%2026-06-30
Smiral Ashwinkumar Patel00%2026-06-30
Tejal Smiral Patel00%2026-06-30
Ashokkumar Parshottamdas Patel00%2026-06-30
Rupesh Kirtibhai Patel00%2026-06-30
Kirtikumar Parshottambhai Patel00%2026-06-30
Shobhnaben Kirtikumar Patel00%2026-06-30
Artiben Manishkumar Patel00%2026-06-30
Patel Dakshaben00%2026-06-30
Ushaben Ashokkumar Patel00%2026-06-30
Pratik Rajendrabhai Gandhi00%2026-06-30
Board of Directors
NameDesignationYear
Smiral Ashwinkumar PatelChairman & Managing Director2025
Manishkumar Jasvantlal PatelNon Executive Director2025
Tejal Smiral PatelExecutive Director / Whole Time Director / CFO2025
Sonu Lalitkumar JainIndependent Non Exe. Director2025
Bhavna ShahIndependent Non Exe. Director2025
Khyati B. ShahIndependent Non Exe. Director2025
Hiral ChudasamaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing and Selling of pharma₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10503333
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000104
2025000101
2025000003
Company Information
Incorporated2010
ChairmanSmiral Ashwinkumar Patel
AuditorDoshi Doshi & Co
Investor Email[email protected]
🌐 www.jfllifesciences.com ↗

📍 309 Satyam Mall Opp Saman Comp, Nr.Vishweshwar Mahadev Mandir, Ahmedabad, Gujarat, 380015

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Jayshree Tea & IndustriesJ B Chemicals and PharmaJBM Auto LimitedJet Freight LogisticsJet Knitwears Ltd.Jeyyam Global Foods Ltd.J.G.Chemicals LimitedJHS Svend. Lab. Ltd.Jindal Photo LimitedJindal Poly Films LimitedJindal SAWJindal Steel LimitedAll “J” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search